![Edward Berg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Berg
General Counsel at
VAXART, INC.
Net worth: 456 998 $ as of 2026-06-29
Profile
Edward B. Berg is General Counsel & Senior Vice President at Vaxart, Inc. since 2022.
Former roles include Vice President & Deputy General Counsel at BioMarin Pharmaceutical, Inc. from 2018 to 2022; Deputy General Counsel-Pharmaceutical Operations at Sanofi-Aventis U.S.
LLC from 2008 to 2018; Vice President at Sandoz, Inc. from 2016 to 2018; Vice President-Legal at Novartis AG from 2016 to 2018; Senior Corporate Counsel-Research & Development at Bristol Myers Squibb Co. from 2006 to 2008; and Senior Attorney & Associate Counsel at Merck & Co., Inc. from 1993 to 2001.
Education includes undergraduate studies at the University of Washington and graduate studies at The University of Pennsylvania Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC. 0.31% | 2026-03-23 | 755,368 ( 0.31% ) | 456 998 $ | 2026-06-29 |
Edward Berg active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | General Counsel | 2022-02-13 |
Former positions of Edward Berg
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 2022-01-31 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | 2018-05-31 |
| NOVARTIS AG | General Counsel | 2018-05-31 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Corporate Officer/Principal | 2018-05-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2008-07-31 |
Training of Edward Berg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
- Stock Market
- Insiders
- Edward Berg
